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Human microvascular endothelial cellsTumor suppressors negatively regulate angiogenesis, an essential step in tumor progression. Together, HPV 16
E6 and E7 proteins, which target p53 and pRb family members, respectively, for degradation, increase the
expression of two angiogenic inducers, VEGF and IL-8, in primary foreskin keratinocytes (HFKs). Conditioned
media from such cells are sufﬁcient to alter endothelial cell behavior. Here, the individual contribution of E6
and E7 to angiogenesis was investigated. E7 and, to a lesser extent E6, increased expression of VEGF and IL-8.
Nevertheless, neither conditioned media from HPV 16 E6 nor E7-expressing HFKs were sufﬁcient to induce
migration of endothelial cells. Conditioned media from HFKs expressing the HPV 16 E6 and the E7 mutant
E7C24G, which can target p107 and p130 but not pRb for degradation, contained increased levels of
VEGF and IL-8. The results suggest that the mechanism of HPV 16 E7-mediated increased levels of VEGF is
pRb-independent.gy and Immunology, Indiana
anapolis, IN 46202-5120, USA.
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The establishment and maintenance of a vascular supply is
required for growth of malignant tissue. Consistent with this,
progression of the premalignant stages to invasive cervical cancer is
associated with the development of new blood vessels, a process
called angiogenesis (Bouck, 1996; Folkman, 2002). Angiogenesis is
crucial for a developing tumor to acquire nutrients and oxygen for
sustained growth and expansion (Bouck, 1996). Angiogenesis is
tightly regulated by a number of secreted factors. According to the
current model of angiogenesis, the vessels seen in normal tissue are
quiescent due to the presence in the microenvironment of elevated
levels of angiogenic inhibitors such as thrombospondin-1 andmaspin,
relative to levels of angiogenic inducers, such as VEGF and IL-8 (Bouck,
1996; Hanahan et al., 1996). As cells progress towards tumorigenicity,
the balance between angiogenic inducers and angiogenic inhibitors is
switched, such that angiogenic inducers dominate.In tumor cells, a link between the functions of tumor suppressors
and angiogenesis has long been established (Gomez-Manzano et al.,
2003; Lee et al., 2003). For example, the tumor suppressor p53
positively regulates the expression of angiogenic inhibitors and
negatively regulates the expression of angiogenic inducers (Volpert
et al., 1997). Similarly, pRb family members regulate expression of
angiogenic factors to maintain a quiescent environment (Gabellini
et al., 2006).
Human papillomaviruses (HPVs) are small double-stranded DNA
viruses that infect mucosal and cutaneous stratiﬁed squamous
epithelia generally of the anogenital tract, head and neck and hands
or feet (Alani and Munger, 1998; Longworth and Laimins, 2004).
There are over 200 genotypes of HPVs. These viruses can cause a wide
range of diseases from benign genital warts to invasive cancer.
Approximately 40 types infect the mucosa and based on their
oncogenic potential these viruses can be divided into two groups:
high-risk HPVs and low-risk HPVs (Munger, 2002). The high-risk HPV
types such as HPV 16, 18, 31, 33 and 45 are mainly associated with the
development of high-grade intraepithelial neoplasias of the anogen-
ital tract, whereas low-risk HPV types such as HPV 6 and 11 aremainly
associated with low-grade abnormalities such as benign condyloma
acuminatum or anogenital warts. The high-risk HPV types 16 and 18
are responsible for more than 70% of cervical cancer cases (Munoz
Fig. 1. Level of IL-8 and VEGF in conditioned media was increased in cells expressing
either E6 or E7. (A) The quantity of IL-8 was determined by ELISA and normalized to
total protein in the conditioned media. The data represent mean±SEM and are
representative of three experiments each conducted in triplicate. pb0.0001 for LXSN vs.
HPV 16E6E7 and LXSN vs. HPV 16E6TTLE7; pb0.001 for LXSN vs. HPV 16E6E7TTL;
pb0.001 for HPV 16E6E7 vs. HPV 16E6TTLE7 and pb0.0005 for HPV 16E6E7 vs. HPV
16E6E7TTL. (B) The quantity of VEGF was determined by ELISA and normalized to total
protein in the conditioned media. The data represent mean±SEM and are
representative of three experiments each conducted in triplicate. pb0.001 for LXSN
vs. HPV 16E6E7; pb0.0001 for LXSN vs. HPV 16E6TTLE7; pb0.001 for LXSN vs. HPV
16E6E7TTL; pb0.0001 for HPV 16E6E7 vs. HPV 16E6TTLE7 and pb0.001 for HPV 16E6E7
vs. HPV 16E6E7TTL.
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to be a precursor to neoplastic transformation (Munoz et al., 2003).
HPV 16-mediated tumorigenicity is dependent on the activity of
two early proteins, E6 and E7. Both in vitro and in vivo studies show
that the functions of E6 and E7, of high-risk types, are necessary for
the induction and maintenance of the transformed phenotype
(Goodwin and DiMaio, 2000; Hawley-Nelson et al., 1989; Kaur et al.,
1989; Munger et al., 1989a; Wells et al., 2000). HPV 16 E6 and E7
contribute to cellular transformation, in part, by binding to and
targeting p53 and pRb family members, respectively, for degradation
(Boyer et al., 1996; Crook et al., 1988; Jones et al., 1997; Scheffner
et al., 1990; zur Hausen, 2002). Degradation of p53 mediated by E6
blocks apoptosis to allow continued proliferation. Degradation of pRb
by E7 results in the activation of E2F transcription factors inducing
cellular genes responsible for the S phase of the cell cycle.
The contribution of HPV 16 E6 and E7 expression to the early
stages of recruitment of a blood supply to an HPV lesion has been
modeled by analysis of primary human foreskin keratinocytes (HFKs)
shortly after transduction with HPV 16 E6 and E7 retrovirus or
transfection with the intact HPV 16 genome. These studies show that
expression of HPV 16 E6 and E7 together in HFKs increases the level of
two angiogenic inducers VEGF and IL-8 (Toussaint-Smith et al., 2004).
Further, conditioned media from cells expressing HPV E6 and E7 are
sufﬁcient to alter endothelial cell behavior (Chen et al., 2007). These
studies, however, did not establish the individual contribution of HPV
16 E6 and E7 to this angiogenic response. To examine the role that E6
and E7 each plays, translational termination linkers (TTLs) were
introduced into the coding region of E6 or E7. The ability of E7 in the
context of the E6TTL mutation (E6TTLE7) and E6 in the context of the
E7TTL mutation (E6E7TTL) to induce VEGF and IL-8 in HFKs was
determined. Both VEGF and IL-8 were signiﬁcantly enhanced in HFKs
expressing either HPV 16E6TTLE7 or HPV 16E6E7TTL. However,
migration assays revealed that conditioned media from neither HPV
16 E6 nor E7-expressing HFKs were able to induce migration of human
microvascular endothelial cells (HMVECs). Immunological depletion
experiments showed that VEGF, butnot IL-8,was required forHPV16E6
and E7 together to induce HMVEC migration. Further experiments
showed that the ability of HPV 16 E7 to induce VEGFmay be dependent
upon degradation of pRb family members p107 and/or p130.
Results
Conditioned media from human foreskin keratinocytes (HFKs) transduced
with HPV 16E6TTLE7 or HPV 16E6E7TTL have elevated levels of IL-8 and
VEGF
Retroviral transduction of HFKs with the HPV 16E6E7 cassette
expressing HPV 16 E6 and E7 (Halbert et al., 1991) results in the
increased expression of angiogenic inducers, IL-8 and VEGF (Toussaint-
Smith et al., 2004). To determinewhether E6 and E7 each contributes to
the increased levels of IL-8 and VEGF, a translation termination linker
was placed into either the E6 or the E7 gene within the HPV 16E6E7
cassette. Pooled HFKs were transduced with parental retrovirus LXSN
or retrovirus encoding HPV 16E6E7, HPV 16E6TTLE7 (expressing E7 in
the context of the HPV 16E6TTL) or HPV 16E6E7TTL (expressing E6 in
the context of the HPV 16E7TTL) and the levels of VEGF and IL-8 in the
conditioned media from the transduced HFKs were determined by
ELISA. Consistent with previous results (Chen et al., 2007; Toussaint-
Smith et al., 2004), relative toHFKs transducedwith LXSN, the level of IL-
8 was increased 8-fold in conditioned media from cells expressing HPV
16 E6 and E7 (HPV 16E6E7). The level of secreted IL-8 in conditioned
media from cells expressing HPV 16E6E7TTL was increased 2.9-fold
compared to parental retrovirus LXSN (pb0.001) (Fig. 1A). A greater
increase, approximately 11.7-fold, was observed in the conditioned
media from cells expressing HPV 16E6TTLE7 compared to parental
retrovirus LXSN (pb0.0001) (Fig. 1A). Also consistent with previousresults, the level of VEGF was increased 1.5-fold in conditioned media
fromcells expressingHPV16E6E7 compared toparental retrovirus LXSN
(pb0.001). The level of secreted VEGF in conditioned media from cells
expressing HPV 16E6E7TTL was increased approximately 2-fold
compared to parental retrovirus LXSN (pb0.001) (Fig. 1B). A greater
increase, approximately 4-fold, was observed from cells expressingHPV
16E6TTLE7 compared to parental retrovirus LXSN (pb0.0001) (Fig. 1B).
Therefore, E6 and E7 each signiﬁcantly increased the levels of IL-8 and
VEGF relative to control, LXSN. However, when compared to HPV
16E6E7, E6 caused a lesser increase in IL-8 and minimal increase in
VEGF; E7 caused a greater increase in both angiogenic inducers.
Conditioned media from HFKs transduced with HPV 16E6TTLE7 or HPV
16E6E7TTL do not induce migration of human microvascular endothelial
cells
Conditionedmedia fromHFKs transducedwithHPV16E6E7 increase
the migration of human microvascular endothelial cells (HMVECs)
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conditioned media from HFKs transduced with E6 or E7 alone were
sufﬁcient to alter endothelial cell behavior. HMVECs were placed in the
top of a transwell plate, conditioned media from control HFKs or HFKs
expressing HPV gene products were placed in the bottom well and
migration wasmonitored. Consistent with previous results (Chen et al.,
2007) conditioned media from HPV 16E6E7-expressing cells increased
the migration of HMVECs (pb0.005) (Fig. 2). In contrast, conditioned
media from retrovirally transduced cells expressing HPV 16E6TTLE7 or
HPV 16E6E7TTL did not induce migration of HMVECs relative to LXSN
(pb0.5 and pb0.3, respectively) (Fig. 2). Consistent with these
observations, the level of migration of endothelial cells seen in the
presence of conditioned media from HPV 16E6E7-expressing cells was
statistically different from that seenwith conditionedmedia fromeither
HPV 16E6TTLE7 orHPV16E6E7TTL (pb0.02). These results indicate that
both E6 and E7 are required to alter endothelial cell behavior. Together
the data indicate that although expression of E7 is sufﬁcient to increase
the levels of VEGF and IL-8 in conditioned media, additional E6-
mediated contributions to the conditioned media are needed to induce
endothelial cell migration.VEGF, but not IL-8, is required for the increased migration of HMVECs in
vitro
Angiogenesis involves activation of endothelial cells. IL-8 and VEGF
have been reported to regulate angiogenesis and affect endothelial cell
migration and proliferation (Heidemann et al., 2003; Olsson et al., 2006;
Rousseau et al., 1997). VEGF is elevated in cervical carcinomas (Smith-
McCune et al., 1997), and IL-8 is elevated in oral squamous cell
carcinomas (Lingen et al., 1996a,b). Data presented in Fig. 2 indicate that
an increase in these two inducers in the conditionedmedia fromHPV E6
or E7-expressing HFKs is insufﬁcient to induce endothelial cell
migration. The requirement for IL-8 and/or VEGF, however, in HPV-
mediated angiogenesis remains unclear. To determine the necessity of
IL-8 and/or VEGF for increasedmigration of endothelial cells seenwhen
HMVECs are exposed to conditioned media from HPV 16E6E7-
expressing cells, neutralizing Abs directed against IL-8 or VEGF or
isotype controls (mouse IgG1 ormouse IgG2B, respectively)were used to
deplete conditionedmediaof IL-8 orVEGF. If IL-8 is successfully depletedFig. 2. Conditioned media from HFKs transduced with either E6 or E7 did not induce
migration of HMVECs in vitro. HMVECs were plated on collagen-coated transwell
membranes. Conditioned media from HFKs retroviral transduced with LXSN, HPV
16E6E7, HPV 16E6TTLE7 and HPV 16E6E7TTL were added to the bottom chamber. After
3 h, six high power ﬁelds (HPF) of cells on the bottom were counted. The results (mean
number of migrated cells per high power ﬁeld (HPF)±SEM) are representative of three
experiments each conducted in triplicate. pb0.005 for LXSN vs. HPV 16E6E7 and pb0.02
for HPV 16E6E7 and HPV 16E6TTLE7 or HPV 16E6E7TTL.and the depletion is speciﬁc, the level of IL-8 following incubation with
antibodies to IL-8 should decrease but the level of VEGF should not.
Similarly, if VEGF is successfully depleted and the depletion is speciﬁc,
the level of VEGF should decrease following incubation with antibodies
to VEGF but the level of IL-8 should not. The level of neither IL-8 nor
VEGF should decrease following incubation with isotype controls. VEGF
or IL-8 was speciﬁcally immunodepleted from the conditioned media
(Fig. 3A and B, respectively). Consistent with the literature (Chen et al.,
2007) and as in Fig. 2, conditioned media from cells expressing HPV
16E6E7 induced migration of HMVECS relative to LXSN, whether the
media were untreated or incubated with the isotype control immu-
noglobulins (Fig. 3C). IL-8-depleted conditioned media from cells
expressing HPV 16E6E7 retained the ability to increase migration of
HMVECs when compared to IL-8-depleted conditioned media from
LXSN transduced cells. However, VEGF-depleted conditioned media
from cells expressing HPV 16E6E7 did not induce migration of HMVECs
when compared to VEGF-depleted conditioned media from LXSN
transduced cells (Fig. 3C). These results indicate that VEGF, but not IL-
8, is required to increase endothelial cell migration in response to
conditioned media from early passage HPV 16E6E7-expressing cells.
pRb degradation is not required for the enhanced expression of VEGF
Data in Fig. 1 indicate that expression ofHPV16E7 is required for the
enhanced levels of IL-8 andVEGF, equivalent toorgreater than the levels
seen with HPV 16E6E7. The LXCXE motif (aa 22–26) of HPV 16 E7
interacts with pRb as well as its other family members, p107 and p130
(Dyson et al., 1992; Munger et al., 1989b). By changing the cysteine at
amino acid 24 to a glycine (C24G), HPV 16 E7 loses afﬁnity for pRb and
the ability to target pRb for degradation (Jones et al., 1997). Therefore,
pooled HFKs were transduced with retrovirus expressing HPV
16E6E7C24G to test the hypothesis that pRb binding and degradation
is required for increased levels of VEGF and IL-8. Consistent with the
results in Fig. 1, expression of HPV 16E6E7 signiﬁcantly increased the
levels of both angiogenic inducers relative to LXSN (Fig. 4A). Condi-
tioned media from cells expressing HPV 16E6E7C24G caused a 2.2-fold
increase in the level of secreted IL-8 compared to retrovirus control
LXSN (pb0.0001), although not to the same extent as seen with
conditioned media from HPV 16E6E7-expressing cells (Fig. 4A). In
contrast, VEGF expression was increased 8.7-fold (pb0.0001) in cells
expressing HPV 16E6E7C24G compared to retrovirus control LXSN
(pb0.0001) (Fig. 4B) and to a greater extent than conditioned media
from HPV 16E6E7-expressing cells (Fig. 4B). Thus, in the presence of
HPV 16 E6, HPV 16 E7 degradation of pRb is not required for enhanced
IL-8 and VEGF expression.
HPV 16E6E7C24G retains its ability to target p130 for degradation
VEGF and p130 expression are inversely correlated (Sanseverino
et al., 2006). Although the HPV 16 E7C24G mutant has been reported
to retain the ability to target another pRb family member, p107, for
degradation (Gonzalez et al., 2001), the ability of this mutant to target
p130 for degradation has not been reported. Therefore, the effect of
HPV 16E6E7C24G on the steady state level of p130was determined by
Western blot analysis. As expected, in cells expressing wild-type E7,
the levels of hypophosphorylated pRb and of p130 in HPV 16E6E7-
expressing cells were decreased relative to LXSN (Fig. 5A, B). The
steady state level of p130, but not pRb, was also decreased in cells
expressing HPV 16E6E7C24G relative to LXSN (Fig. 5A, B). As has been
reported when HPV 16 E6 alone is expressed (Malanchi et al., 2004),
relative to LXSN, the steady state level of pRb was increased in cells
infected with HPV 16E6E7C24G (Fig. 5A). Relative to LXSN, as
expected, p53 expression was decreased in cells infected with HPV
16E6E7C24G (Scheffner et al., 1990), similar to the decrease seen
with HPV 16E6E7 (Fig. 5C). These results demonstrate that HPV
Fig. 3. VEGF, but not IL-8, is required for the increasedmigration of HMVECs in vitro. Conditionedmedia (CM) fromHFKs retrovirally transduced with LXSN and HPV 16E6E7 depleted
of (A) IL-8 or (B) VEGF were (C) tested for the ability to induce migration of endothelial cells as in Fig. 2. The results (mean number of migrated cells per high power ﬁeld (HPF)±
SEM) are representative of three experiments each conducted in triplicate. pb0.0001 for LXSN vs. HPV 16E6E7 (control isotype IgG2B); pb0.002 for LXSN vs. HPV 16E6E7 (depleted
IL-8) and LXSN vs. HPV 16E6E7 (control isotype IgG1).
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retained the ability to decrease the steady state level of p130.Discussion
Increased angiogenesis has been correlated with progression of
HPV lesions from premalignant dysplasia to malignancy. The onset of
angiogenesis, both in an HPV 16 early region transgenic mouse model
and in HPV 16-positive human cervices, is seen early in this process
(Smith-McCune et al., 1997). Further, the direct contribution of HPV
16 E6 and E7 to angiogenesis has been demonstrated. Human foreskin
keratinocytes expressing HPV 16 E6 and E7 contain higher levels of
VEGF and IL-8 mRNA (Toussaint-Smith et al., 2004). Conditioned
media taken from primary foreskin keratinocytes soon after their
transduction with HPV 16 E6 and E7 contain increased levels of VEGF
and IL-8 and enhance angiogenesis when introduced into mice in a
Matrigel plug (Bequet-Romero and Lopez-Ocejo, 2000; Chen et al.,
2007; Toussaint-Smith et al., 2004). In the present study, the
individual contributions of HPV 16 E6 and E7 oncoproteins in
regulating the angiogenic response seen in the early stages of cervical
cancer were elucidated. To do so, translation termination linkers were
introduced into the coding regions of HPV 16 E6 or E7. E6 in the
context of the E7TTL mutation (E6E7TTL) and E7 in the context of the
E6TTL mutation (E6TTLE7) in human foreskin keratinocytes led to a
signiﬁcant increase in VEGF and IL-8 secretion (Fig. 1).Several mechanisms could account for how HPV 16 E6 and E7 each
increase the levels of IL-8 and VEGF. One possibility is that E6 and/or
E7 increases IL-8 and VEGF protein levels by affecting transcription
factors that bind cognate sites located on the promoters of their
respective genes. IL-8 transcription is regulated through cooperation
with three inducible transcription factors, NFκB, AP-1 and C/EBP
(Hoffmann et al., 2002). HPV 16 E6 is able to transactivate promoters
containing NFκB sites (Desaintes et al., 1992; James et al., 2006; Nees
et al., 2001). HPV 16 E7 is able to transactivate promoters containing
AP-1 sites (Antinore et al., 1996) as well as promoters containing C/
EBP responsive elements (Muller et al., 1999). E6 can stimulate
several promoters through their Sp-1 responsive elements (Desaintes
et al., 1992) and speciﬁcally stimulates the VEGF promoter through
Sp-1 sites via a p53 independent mechanism (Lopez-Ocejo et al.,
2000). E7 may also transactivate AP-1 sites on the VEGF promoter
(Antinore et al., 1996). Alternatively E6 and E7 may stimulate
transcription of IL-8 and VEGF through interactions with the basal
transcription machinery (Desaintes et al., 1992; Massimi et al., 1996;
Phillips and Vousden, 1997). Finally, E7 may alter expression of these
angiogenic factors by causing chromosomal remodeling by interacting
with histone deacetylases (Bernat et al., 2003; Brehm et al., 1999).
Transcription of VEGF is also upregulated by hypoxia inducible
factor (HIF-1) (Bardos and Ashcroft, 2005; Brat et al., 2003). Under
normoxic conditions, HIF-1α is hydoxylated by prolyl hydroxylases
and targeted for degradation by the VHL E3 ubiquitin ligase complex
(Epstein et al., 2001). HPV 16 E7 appears to replace VHL in this
Fig. 4. Levels of IL-8 and VEGF in conditioned media were increased in cells expressing
HPV 16E6E7C24G. The experiment was conducted as in Fig. 1. (A) The quantity of IL-
8 was determined by ELISA and normalized to total protein in the conditioned media.
The data represent mean±SEM and are representative of three experiments each
conducted in triplicate. pb0.0001 for LXSN vs. HPV 16E6E7; LXSN vs. HPV 16E6E7C24G
and pb0.0002 for HPV 16E6E7 vs. HPV 16E6E7C24G. (B) The quantity of VEGF was
determined by ELISA and normalized to total protein in the conditionedmedia. The data
represent mean±SEM and are representative of three experiments each conducted in
triplicate. pb0.001 for LXSN vs. HPV 16E6E7; LXSN vs. HPV 16E6E7C24G and pb0.0003
for HPV 16E6E7C24G vs. HPV 16E6E7.
Fig. 5. HPV 16E6E7C24G, which does not associate with pRb, is still capable of targeting
p130 for degradation. Whole cell lysates from HFKs transduced with LXSN, HPV 16E6E7
and HPV 16E6E7C24G, were analyzed by Western blot to determine the steady state
levels of (A) pRb, (B) p130, (C) p53 expression. Tubulin serves as a loading control.
*, unknown cross-reacting protein.
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that another mechanism by which E7 could enhance the level of VEGF
would be through increasing the level of HIF-1 in normoxic
conditions. However, neither HIF-1α nor HIF-2α (another inducer
of VEGF) was elevated in any of the transduced HFKs under normoxic
conditions (data not shown).
Data shown in Fig. 1 suggest that E7 is the major contributor to the
increased expression of VEGF and IL-8. While this could be because E7
has a greater ability to alter the level of transcription of these two
angiogenic inducers, another possibility could relate to the level of E7
versus E6 produced by the different HPV 16E6E7 wild-type or
mutated cassettes. Expression of HPV 16E6E7 within the retroviral
vector favors unspliced bicistronicmRNA and translation of E6 (Zheng
et al., 2004) (Tang et al., 2006). Premature termination of E6, brought
about by splicing of the bicistronic mRNAwithin E6, favors translation
of E7 (Tang et al., 2006). This suggests that placement of the TTL
within E6 (at nt 280) would not only result in premature terminationof E6 but would similarly enhance translation of E7. Further, we noted
that the introduction of the TTL into E6 enhanced the level of splicing
(data not shown), again enhancing E7 translation. Thus, the quantity
of E7 in the HPV 16E6TTLE7 recombinant retrovirus may be greater
than that produced by the HPV 16E6E7 recombinant retrovirus.
Functionally, conditioned media from either HPV 16 E6 or E7-
expressing cells did not induce migration of human microvascular
endothelial cells (HMVECs) (Fig. 2). This is in marked contrast to the
ability of E6 and E7 together to induce HMVEC migration. These
results indicate that the increased levels of VEGF and IL-8 seen in the
presence of E7 are insufﬁcient to induce an angiogenic response. Since
angiogenesis requires a shift in the ratio of angiogenic inhibitors to
inducers, to favor the latter, the data suggest that other components in
the conditioned media must be altered by HPV 16 E6 expression
within HFKs for this switch to occur. In an HPV 16 transgenic mouse
model of estrogen-dependent cervical carcinogenesis, E6 expression
does not cause malignancy while E7 expression gives rise to cervical
tumors which are smaller than those seen with E6 and E7 (Riley et al.,
2003).While the underlyingmechanisms responsible for these results
may be many, based on our data one contributor may be the limited
ability of either oncoprotein alone to provide the appropriate
microenvironment for maximal tumor growth. It will be informative
to determine whether combining conditioned media from E6-
expressing cells with conditioned media from E7-expressing cells
results in media competent to alter HMVEC migration.
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is pRb-independent (Figs. 4 and 5). One possible mechanism for
the increase in VEGF expression is through degradation of pRb
family member p130. Sanseverino et al. 2006 found that VEGF and
p130 expression were inversely correlated in endometrial cancers
(Sanseverino et al., 2006). Speciﬁcally, immunohistochemical staining
showed low VEGF staining correlated with high expression of p130
while higher levels of VEGF correlated with low expression of p130
(Sanseverino et al., 2006). Alternatively, the pRb-independent activity
of E7 could be due to degradation of p107 (Gonzalez et al., 2001) or
the interactions, for example with AP-1or histone deacetylases, which
are retained with the HPV 16 E7C24G mutant (Antinore et al., 1996;
Brehm et al., 1999). A functional analysis of the conditioned media
from cells expressing HPV 16 E6E7C24G will establish whether, in the
context of E6, pRb-independent activities of E7 are sufﬁcient to the
altered endothelial cell behavior.
Although the level of IL-8 is greater in conditioned media from
cells expressing HPV 16E6E7C24G when compared to conditioned
media from control (LXSN) cells, the level of IL-8 is not as great as that
produced by HFKs expressing wild-type E7 (HPV 16 E6E7, Fig. 4). The
fold increase in IL-8 with HPV 16E6E7C24G is similar to that seen with
HPV 16E6E7TTL (compare Fig. 4 to Fig. 1). This suggests that pRb-
dependent functions of E7 contribute to the increased expression of
IL-8.
Using speciﬁc blocking antibodies to IL-8 or VEGF, we showed that
VEGF was required for HPV 16 E6 and E7 together to induce HMVEC
migration (Fig. 3). Thus blockade of either E6 or E7 and VEGF expression
may result in suppression of an angiogenic response in vivo.
Finally, although this research focused on the HPV 16 E6 and E7
proteins, conditioned media from cervical keratinocytes stably
transfected with the intact HPV 16 genome also increase endothelial
cell proliferation and migration in vitro and recruit a blood supply in
vivo (Chen et al., 2007). To understand the role that altered
expression of angiogenic factors plays in the viral life cycle, it will
be important to determine the ability of the low-risk HPV genome and
E6 and/or E7 to alter expression of these factors.
In summary, our ﬁndings suggest the following: (i) HPV 16 E6 and
E7 each upregulates the level of VEGF and IL-8 in conditioned media;
(ii) neither conditioned media from HPV 16 E6 nor E7-expressing
HFKs induce migration of HMVECs; (iii) VEGF, but not IL-8, is required
for HPV 16 E6 and E7 together to induce HMVEC migration; and
(iv) the increased level of VEGF induced by HPV 16 E7 is independent
of pRb binding and degradation.
Materials and methods
Cell culture and retroviral infection
Human foreskin keratinocytes (HFKs) were prepared as previously
described (Chenet al., 2007; Toussaint-Smithet al., 2004;Wuet al., 1982)
and cultured in complete keratinocyte serum free media (C-KSFM)
supplemented with human recombinant epidermal growth factor
(GIBCO/BRL) and bovine pituitary extract (GIBCO/BRL). Pooled HFKs
were grown to about 40% conﬂuence and infected with 5 ml of the
recombinant retrovirus encoding HPV 16E6E7, HPV 16E6TTLE7, HPV
16E6E7TTL,HPV16E6E7C24Gorparental virus LXSNand8 μgpolybrene/
ml. After 6 h the culture media were aspirated and fresh C-KSFM added.
The neomycin resistance gene expressed within the vector, allowed
selection of infected cells with 200 μg/ml G418 for 3 days. Selected cells
were expanded and used for further experiments.
Human dermal microvascular endothelial cells (HMVECS) (Cam-
brex)wereobtained atpassage7or 8. Cellswere seeded in tissue culture
ﬂasks coated with type 1 rat tail collagen (BD Biosciences) in complete
endothelial cell growth medium-2 (EGM-2) (Lonza) supplemented
with 10% FBS (Hyclone) and 1% antibiotic/antimycotic (100 U/ml
penicillin/streptomycin and 25 μg of amphotericin B) (Invitrogen).Cells were collected for passage with trypsin (Invitrogen), and
centrifuged at 500 ×g for 5 min. Cells were resuspended in 5 ml EBM-
2 and live cells counted by trypan blue exclusion on a hemocytometer.
Three to 5×105 live cells were seeded in 75 cm2 ﬂasks precoated with
type 1 rat tail collagen.
Mutational analysis
HPV 16E6E7 was generated similar to the HPV 16E6E7 cassette
previously cloned into the retrovirus LXSN by the Galloway laboratory
(Halbert et al., 1991). The original cloning strategy, however, did not
allow manipulation of the cassette. Brieﬂy, DNA fragment nt 56–883,
encompassing E6 and E7, was PCR ampliﬁed with the following
primers containing BamHI and EcoRI sites: 5’-CGGAATTCACCGGT-
TAGTATAAAAGC-3’ and 5’-CGCGGATCCGGATCAGCCATGGTAGAT-
TATGG-3’. The HPV-16 E6 and E7 mutants, HPV 16E6TTLE7 and
HPV 16E6E7TTL, were generated using the Quick-Change site-
directed mutagenesis kit (Stratagene) according to manufacturer’s
instructions. Oligonucleotides for HPV 16E6TTLE7 (5’-GTATATAGA-
GATGGGAATCCTTAGTTAACTAAATATGCTGTATGTG-3’ and 5’-CACA-
TACAGCATATTTAGTTAACTAAGGATTCCCATCTCTATATAC-3; HPV
16E6E7TTL 5’-CCGGACAGAGCCTTAGTTAACTAACATTACAATATTG-
TAACC-3’ and 5’-GGTTACAATATTGTAATGTTAGTTAACTAAGGCTC
GTCCGG-3’) were designed based on the published sequence for
HPV 16 (Seedorf et al., 1985) with the translation termination linker
(TTL) sequence and placement taken from Munger et al., 1989a, to
preclude expression of E6 or E7. The presence of TTLs in the E6 and E7
ORFs was veriﬁed by presence of an engineered HpaI site within the
linker. The HPV 16E6E7C24G pRb binding deﬁcient mutant was
generated by site-directed mutagenesis. Site-directed mutagenesis
was performed using the Quick-Change II XL site-directed mutagen-
esis kit (Stratagene) according to manufacturer’s instructions. The
following oligonucleotides (Invitrogen) were used to introduce a
single amino acid substitution at residue 24: 5’-CAGAGACAACT-
GATCTCTACGGTTATGAGCAATTAAATGAC-3’ and 5’-GTCATT-
TAATTGCTCATAACCGTAGAGATCAGTTGTCTCTG-3’) based on the
published sequence (Seedorf et al., 1985). The plasmid DNAs were
subcloned into the BamHI (Invitrogen) and EcoRI (Invitrogen) sites of
the pLXSN vector. Plasmids were sequenced to conﬁrm the presence
of corresponding mutation.
Collection of condition media (CM)
Following selection, retrovirally transduced HFKs were transferred
1:4 onto mitomycin C (4 μg/ml in ddH2O, Sigma) treated NIH-3T3 J2
ﬁbroblasts and grown in complete E media until 80% conﬂuence
(passage 2). At passage 3, 2.5×106 cells were plated in E media in
10 cm plates with 2×105 feeder cells for 24 h. Serum-free conditioned
media (Lingen et al., 1996b) were generated by rinsing the cells
three timeswith 4 ml of basalmedia (BM) (3 parts DMEM/1 part Ham's
F-12 with 100 U/ml of penicillin and 100 μg/ml of streptomycin),
incubating the cells for 4 h in BM, replacing this media with 8 ml of the
same media and harvesting CM 24 h later. For functional assays, CM
were concentrated 30× using 15 ml Amicon Ultracel (Millipore)
centrifugal ﬁlter devices (10000 MWCO) at 4 °C for 45 min at
3000 rpms. Protein concentrations were determined using the Bio-
Rad DC protein assay kit.
Western blot analysis
Whole cell lysates were prepared by using 1× lysis buffer (20 mM
Tris, pH 6.8, 1% sodium dodecyl sulfate (SDS), 1 mM EDTA) plus
protease and phosphatase inhibitor cocktail (20 μM Na3VO4 and
100 mM NaF, Sigma) and protein concentrations were determined by
using the Bio-Rad (Bradford) protein assay. SDS-PAGE and Western
blotting were performed as previously described using 50 μg of
289J. Walker et al. / Virology 410 (2011) 283–290protein (Chen et al., 2007). Primary antibodies were diluted in TBS-t
supplemented with 5% nonfat dry milk used at the following dilutions
as previously described (Chen et al., 2007; Toussaint-Smith et al.,
2004; Zhang et al., 2006): p53 (DO-1 Sc-126, Santa Cruz) 1:1000, pRb
(BD Pharminogen) 1:1000; Rb2 (p130, BD Bioscience) 1:1000; and
loading controls GAPDH (MAB 374, Chemicon) 1:30,000 and tubulin
(Sigma) 1:3000. Secondary goat anti-mouse horseradish peroxidase
(HRP) (Bio-Rad) was diluted 1:5000 into TBS-t for 1 h. The Pierce ECL
Western blotting substrate (Thermo Scientiﬁc) protein detection
system was used to visualize proteins. Densitometry was performed
using Quantity One software (Bio-Rad).Depletion of IL-8 or VEGF from CM
Concentrated CM (500 μg) from LXSN and HPV 16E6E7 were
incubated with 10 μg of mouse monoclonal neutralizing antibodies
(Abs) directed against IL-8 (R&D Systems, MAB208), VEGF (R&D
Systems, MAB 293), or isotype controls (IgG1 for IL-8, R&D Systems,
MAB002 or IgG2B for VEGF R&D Systems, MAB 004) and rotated for 2 h
at 4 °C. Twentymicroliters of 50% vol/vol of protein G sepharose beads
(Delorme et al., 2001) in 1× phosphate buffered saline (PBS) was
added and rotated for 2 h. The beads were then centrifuged at
4000 rpm for 30 s and the supernatants were collected into microfuge
tubes. The protein concentration of the supernatants was determined
using the Bio-Rad DC protein assay kit and used for ELISA and
migration assays.ELISA analysis
VEGF165 secretion was detected in unconcentrated CM using the
Quantikine Human VEGF ELISA kit (R&D systems) according to the
manufacturer's protocol. IL-8 secretion was detected in unconcen-
trated CM using the Quantikine Human CXCL8/IL-8 ELISA kit (R&D
systems).In vitro endothelial cell migration assay
The endothelial cell migration assay was performed as previously
described (Chen et al., 2007) with minor modiﬁcations. Brieﬂy, the
upper and lower chamber of the transwell inserts (8 μm pore ﬁlter;
Costar) were coated with 60 μl of type I rat tail collagen 50 μg/ml (BD
Pharmingen) and incubated for no more than 90 min at 37 °C, 5% CO2.
The collagen was aspirated and the transwell inserts were placed into
individual wells of a 24-well tissue culture plate. Human dermal
microvascular endothelial cells (HMVECs) (2×104 cells) were
resuspended in 100 μl of EBM-2 (Cambrex) supplemented with 0.5%
BSA and added to the top of each transwell. Six hundredmicroliters of
EBM-2 supplemented with 0.5% BSA, VEGF (50 ng/ml, Peprotech) or
conditioned media (50 μg) from retrovirally transduced HFKs were
added to the lower chamber of each transwell. After 3.5 h of
incubation at 37 °C, non-migrating cells were removed using a cotton
swab. The migrating cells that attached to the bottom surface of the
membrane were ﬁxed with 600 μl of methanol and stained with Diff-
quick kit (Invitrogen). The number of migrated cells per membrane
was determined by counting six high power ﬁelds (HPFs) on the
bottom of the membrane with an inverted microscope at 20×
magniﬁcation. Assays were performed in triplicate.Statistical analysis
Student unpaired two tailed t-test (Prism GraphPad 4.0) was used
for statistical analysis. A probability value of less than 0.05 was
considered signiﬁcant.Acknowledgments
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